BioXcel Therapeutics, Inc. Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay
BioXcel Therapeutics, Inc. (BTAI) reported Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay of 5.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent · last filed 2026-03-27
- BioXcel Therapeutics, Inc. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2025 was 5.00%, a 0.00% change from fiscal 2024.
- BioXcel Therapeutics, Inc. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2024 was 5.00%, a 0.00% change from fiscal 2023.
- BioXcel Therapeutics, Inc. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2023 was 5.00%, a 0.00% change from fiscal 2022.
- BioXcel Therapeutics, Inc. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2022 was 5.00%.
| Period end | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 12 month |
|---|---|
| 2025-12-31 | 5.00% 10-K · filed 2026-03-27 |
| 2024-12-31 | 5.00% 10-K · filed 2025-03-28 |
| 2023-12-31 | 5.00% 10-K · filed 2024-03-22 |
| 2022-12-31 | 5.00% 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |